Table 2.
Parameter | Category vs reference | ARRR | p value |
---|---|---|---|
Univariable Poisson regression analysis | |||
Sex | Male vs female | 0.861 | 0.557 |
Age at baseline (years) | ≤ 40 vs > 40 | 1.082 | 0.753 |
Disease duration at baseline (years) | ≤ 5 vs > 5 | 0.787 | 0.333 |
Number of relapses in the year prior to baseline | ≤ 1 vs > 1 | 0.377 | < 0.001 |
Number of prior DMTs | ≤ 1 vs ≥ 2 | 0.546 | 0.008 |
Baseline EDSS | ≤ 3 vs > 3 | 0.900 | 0.677 |
Multivariable Poisson regression analysis; 299 observations | |||
Sex | Male vs female | 0.846 | 0.463 |
Disease duration at baseline (years) | ≤ 5 vs > 5 | 0.826 | 0.388 |
Number of relapses in the year prior to baseline | ≤ 1 vs > 1 | 0.356 | < 0.001 |
Number of prior DMTs | ≤ 1 vs ≥ 2 | 0.535 | 0.004 |
ARRR annualized relapse rate ratio, DMT disease-modifying therapy, EDSS expanded disability status scale